Skip to main content

Implications of White Paper for General Practitioners

In the period since the establishment of the new coalition government, we have seen radical changes proposed for the NHS in England. These are laid out in the new White Paper, Equity and Excellence: Liberating the NHS. These changes will have major implications for GPs and will lead to a period of major organisational change in the NHS in England. This is turn may lead to some general practices having less time to support non-core activities such as teaching and research.

GP contracts
The Government plans to abolish the current General Medical Services (GMS) and Personal Medical Services (PMS) contracts and bring in a new single contract for all general practitioners (GPs) in England. This new contract will include responsibility for commissioning health services. The White Paper also discusses linking GPs’ pay more closely to health outcomes (but it is currently unclear how this will be achieved in practice). The White Paper states that the Government ‘seeks over time to establish a single contractual and funding model to promote quality improvement, deliver fairness for all practices, support free patient choice and remove unnecessary barriers to new provision’. The new contract remains to be negotiated with the British Medical Association’s General Practice Committee (GPC) and hence the detailed content of the contract is yet to be agreed.

GPs to take on responsibility for commissioning 
When the changes proposed in the White Paper are implemented, GPs will take on responsibility for commissioning the great majority of NHS services. Linked to this process will be an attempt to reduce management costs by abolishing SHAs (2012) and PCTs (2013). Under the new arrangements consortiums of GP practices will hold budgets to commission health services. At present, it is unclear how the other non-commissioning roles of PCTs will be carried out (e.g. research governance).

All general practices will have to join a consortium by the autumn of 2012; and from April 2013 will be funded directly by the new NHS Commissioning Board. GP consortiums will be able to employ staff to help them carry out their day to day administrative and management functions. Not all GPs will have to be actively involved in all aspects of commissioning, but every practice will need to take on basic commissioning responsibilities, such assessing the cost of specialist referrals. Each member practice is expected to work within the same financial framework.

Incentives for GP commissioning consortiums 
Although the Secretary of State for Health (Andrew Lansley) has promised ‘powerful incentives’ for GPs to take on commissioning, it is likely that these financial incentives will have to come out of existing resources (unlike for example with the implementation of GP fundholding, when additional resources were made available to participating practices). A proportion of GP practice income will be linked to commissioning, with GPs able to earn a ‘quality premium’ if their consortium hits targets for clinical outcomes and financial performance set by the NHS board. This means that consortiums will have to look closely at the use of resources by their general practices (particularly prescribing costs, referrals to specialists and unplanned admissions). It is also possible that general practices could lose a proportion of their existing income (through failing to achieve the targets to receive the ‘quality premium’ payment) if their consortium overspends. This will create strong pressure on GPs to stay within their allocated budgets.

Management of general practices
The new National NHS Commissioning Board will be responsible for managing GP consortiums. The board will also hold general practice contracts, but may devolve the task of monitoring practice performance to local consortiums. This proposal has been resisted by some consortiums that do not want to take on this policing role. Andrew Lansley has said there will be ‘no bail out’ for GP consortiums, which he expects to take on the financial risk of commissioning. Risk will not, however, be shared with individual practices, who will not be penalised financially in the event of an overspend, other than through the loss of their quality premium. The NHS Commissioning Board will have the power to intervene if consortiums are at significant risk of failure, to impose measures to limit any overspend (such as reducing referral and admission activity), and in extreme circumstances to sanction temporary payments to keep consortiums solvent. Consortiums that overspend consistently are likely to be forced to undergo remedial action and may ultimately be stripped of their commissioning responsibilities. The number and size of GP consortiums remains to be determined.

Conclusions
The changes in the White Paper will lead to major changes in the way in which GPs work and in the management of their practices. In my department, we will be working to evaluate the impact of these changes on general practices, health outcomes and public health.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.